Development and Validation of a Prediction Model for Depression and Anxiety in Perioperative Elderly Adults
NCT ID: NCT05600504
Last Updated: 2024-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
6386 participants
OBSERVATIONAL
2020-04-01
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of Anxiety and Depression Among Elderly People
NCT06006234
The Impact of Depression and/or Anxiety on PCI Patients
NCT03057691
Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics
NCT03219008
Neurofeedback Training For Older Adults
NCT05936697
A Tripartite Biopsychosocial Intervention Program Enhances Mental Health and Quality of Life in Elderly Patients With Depression Secondary to Geriatric Diseases
NCT07002385
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Previous studies have found a 31 percent risk of anxiety and 29 percent risk of depression in older perioperative patients. Therefore, optimizing perioperative mental health management in older patients remains one of the challenges facing clinicians.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No depression
no intervention
no intervention
no intervention
Depression
no intervention
no intervention
no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. American society of Aneshesiologists (ASA) classification Ⅰ \~ Ⅲ,
3. patients over age 65.
Exclusion Criteria
2. missing data exceeding 20%,
3. went to ICU or died after surgery,
4. have a history of any mental disorders such as epilepsy, Parkinson's disease, depression, anxiety, sleep disorders, or are currently taking relevant intervention drugs 5) patients with severe deafness, dementia or speech impairment.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University First Hospital
OTHER
Peking University People's Hospital
OTHER
Shanghai Zhongshan Hospital
OTHER
Fudan University
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
The Affiliated Hospital Of Guizhou Medical University
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
Taihe Hospital
OTHER
Capital Medical University
OTHER
Beijing Tiantan Hospital
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
First Affiliated Hospital of Xinjiang Medical University
OTHER
China-Japan Friendship Hospital
OTHER
Sun Yat-sen University
OTHER
Chinese PLA General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Weidong Mi
Director (Cheif expert of National key research and development program of China 2018YFC2001900)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Weidong Mi, PhD
Role: STUDY_CHAIR
Chinese PLA General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PLAGH-DA-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.